| 2026-07-14 | 8-K | 10.1 | Amendment No. 3 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan |
|---|
| 2026-07-02 | 8-K | 10.1 | Amendment to Employment Agreement, effective June 30, 2026, between Cingulate Therapeutics, LLC and Matthew N. Brams |
|---|
| 2026-03-18 | 10-K | 10.16 | Employment Agreement, effective October 13, 2025, between Cingulate Therapeutics LLC and Bryan Downey |
|---|
| 2026-03-18 | 10-K | 10.13 | Employment Agreement, effective January 1, 2026, between Cingulate Therapeutics LLC and Raul R. Silva |
|---|
| 2026-03-18 | 10-K | 10.9 | Separation Agreement and Release of All Claims, effective August 7, 2025, between Cingulate Therapeutics LLC and Laurie A. Myers |
|---|
| 2026-03-18 | 10-K | 10.7 | Employment Agreement, effective January 1, 2026, between Cingulate Therapeutics LLC and Matthew N. Brams |
|---|
| 2026-01-28 | 8-K | 10.1 | Form of Securities Purchase Agreement, dated as of January 27, 2026, by and among the Company and the Purchasers. |
|---|
| 2025-12-15 | 8-K | 10.1 | Amended and Restated Employment Agreement, dated December 15, 2025, between Cingulate Therapeutics LLC and Shane J. Schaffer |
|---|
| 2025-11-10 | 8-K | 10.2 | Guaranty by Cingulate Therapeutics LLC and Cingulate Works, Inc., dated November 7, 2025 |
|---|
| 2025-11-10 | 8-K | 10.1 | Note Purchase Agreement between Cingulate Inc. and Avondale Capital, LLC, dated November 7, 2025 |
|---|
| 2025-08-19 | 10-Q | 10.3 | Employment Agreement, dated July 8, 2025, between Cingulate Therapeutics LLC and Nilay D. Patel |
|---|
| 2025-07-22 | 8-K | 10.2 | Registration Rights Agreement, dated July 21, 2025, by and between the Company and Lincoln Park Capital Fund, LLC |
|---|
| 2025-07-22 | 8-K | 10.1 | Purchase Agreement, dated July 21, 2025, by and between the Company and Lincoln Park Capital Fund, LLC |
|---|
| 2025-06-11 | 8-K | 10.1 | Amendment No. 2 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan |
|---|
| 2025-05-08 | 10-Q | 10.4 | Master Services Agreement, effective May 7, 2025, between Indegene, Inc. and Cingulate Therapeutics LLC |
|---|
| 2025-04-09 | 8-K | 10.1 | Grant Agreement dated April 8, 2025 |
|---|
| 2025-03-27 | 10-K | 10.3 | Amendment No. 1 to Master Services Agreement, effective February 12, 2025, between Cingulate Therapeutics LLC and Societal CDMO, Inc. (DBA Bend Bioscience) |
|---|
| 2025-01-24 | 8-K | 10.1 | Amendment to Employment Agreement, effective January 1, 2025, between Cingulate Therapeutics, LLC and Matthew N. Brams |
|---|
| 2024-12-23 | 8-K | 10.2 | Guaranty by Cingulate Therapeutics LLC and Cingulate Works, Inc., dated December 20, 2024 |
|---|
| 2024-12-23 | 8-K | 10.1 | Securities Purchase Agreement between Cingulate Inc. and Streeterville Capital, LLC, dated December 20, 2024 |
|---|
| 2024-07-01 | 8-K | 10.1 | Form of Inducement Letter. |
|---|
| 2024-06-12 | 8-K | 10.1 | Amendment No. 1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan |
|---|
| 2024-02-07 | 8-K | 10.1 | Form of Securities Purchase Agreement |
|---|
| 2024-01-29 | 8-K | 10.2 | Employment Agreement, dated January 25, 2024, between Cingulate Therapeutics LLC, and Jennifer L. Callahan |
|---|
| 2024-01-29 | 8-K | 10.1 | Note Conversion Agreement, dated January 25, 2024, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC |
|---|
| 2023-09-11 | 8-K | 10.1 | Note Conversion Agreement, dated September 8, 2023, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC |
|---|
| 2023-08-14 | 8-K | 10.1 | Securities Purchase Agreement, dated August 11, 2023, by and between the Company and Werth Family Investment Associates LLC |
|---|
| 2023-05-10 | 10-Q | 10.5 | Amendment to ATM Agreement, dated May 2, 2023, by and between Cingulate Inc. and H.C. Wainwright & Co., LLC |
|---|
| 2023-05-10 | 8-K | 10.1 | Amended and Restated Promissory Note, dated May 9, 2023, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC |
|---|
| 2023-04-25 | 8-K | 10.2 | Registration Rights Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC |
|---|
| 2023-04-25 | 8-K | 10.1 | Purchase Agreement, dated April 24, 2023, by and between the Company and Lincoln Park Capital Fund, LLC |
|---|
| 2023-03-10 | 10-K | 10.19 | Form of Incentive Stock Option Award under 2021 Plan |
|---|
| 2023-03-10 | 10-K | 10.10 | Amendment to Employment Agreement, effective January 1, 2023, between Cingulate Therapeutics LLC and Raul R. Silva |
|---|
| 2022-10-25 | 8-K | 10.1 | Master Services Agreement between Cingulate Therapeutics LLC and Societal CDMO, Inc., dated October 24, 2022 |
|---|
| 2022-08-11 | 10-Q | 10.1 | Amendment to Employment Agreement, effective April 1, 2022, between Cingulate Therapeutics LLC and Raul R. Silva |
|---|
| 2022-08-11 | 8-K | 10.1 | Promissory Note, dated August 9, 2022, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC |
|---|
| 2022-05-12 | 10-Q | 10.2 | Form of Incentive Stock Option Award under 2021 Plan |
|---|
| 2022-05-12 | 10-Q | 10.1 | Form of Nonqualified Stock Option Award under 2021 Plan |
|---|